Improvement in early function of the hepatic graft after treatment of the donor with N-acetylcysteine: clinical study.
Regueira
F M
FM
Department of Surgery, University Clinic of Navarra, Pamplona, Spain.
Cienfuegos
J A
JA
Pardo
F
F
Hernández
J L
JL
Díez-Caballero
A
A
Sierra
A
A
Nwose
E
E
Espí
A
A
Baixaulí
J
J
Rotellar
F
F
D000111:Acetylcysteine / Q000627:therapeutic use*; D000241:Adenosine; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D000493:Allopurinol; D001219:Aspartate Aminotransferases / Q000097:blood; D001646:Bile / Q000378:metabolism; D001663:Bilirubin / Q000097:blood; D005978:Glutathione; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007328:Insulin; D016031:Liver Transplantation / Q000401:mortality / Q000502:physiology*; D008875:Middle Aged; D009926:Organ Preservation / Q000379:methods*; D019188:Organ Preservation Solutions; D011517:Prothrombin Time; D011887:Raffinose; D015996:Survival Rate; D014019:Tissue Donors
D007328:Insulin; D019188:Organ Preservation Solutions; C055206:University of Wisconsin-lactobionate solution; D000493:Allopurinol; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D005978:Glutathione; D000241:Adenosine; D011887:Raffinose; D001663:Bilirubin; D000111:Acetylcysteine